Rachel Oliverio, DO
Occupational Medicine · West Burlington, IANPI 1447454145
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $392 of the $453 with a category attached, or 86.5%. 8 manufacturers reported payments, led by Organogenesis Inc. at 46.2% of the total. Reporting peaked in 2022 at $168 and has fallen 82.2% since, to $30 in 2025.
Across 17 payments — averaging $26.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$209
- Kerecis Limited$84
- KCI USA, Inc.$38
- Solventum Corporation$36
- Smith+Nephew$29
- Hartmann USA, Inc.$28
- plus $29 from 2 others
What the payments were for
- Travel & lodging$6113%
- Food & beverage$39287%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 4 | $209 |
| Kerecis Limited | 4 | $84 |
| KCI USA, Inc. | 2 | $38 |
| Solventum Corporation | 2 | $36 |
| Smith+Nephew | 2 | $29 |
| Hartmann USA, Inc. | 1 | $28 |
| AbbVie | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$113
How this compares
Too few occupational medicine providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 266 | $2,082 |
| Mometasone Furoate | 94 | $1,644 |
| Gentamicin Sulfate | 28 | $997 |
| Silver Sulfadiazine | 11 | $254 |
| Fluconazole | 20 | $137 |
| Ciprofloxacin Hcl | 20 | $136 |
| Clindamycin Hcl | 15 | $92 |
| Levofloxacin | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other occupational medicine in West Burlington
- Shirley PospisilIowa City$161K
- Charles MooneyClarion$341
- Matthew DotyPella$320
- Mark TaylorCedar Rapids$147
- Geeta MahadeviaDavenport$129
- Rick GarrelsBettendorf$67
- Sarvenaz JabbariWaterloo$62
- Erin KennedyCedar Falls$62
- Douglas MartinSioux City$61
- Joseph MorelloIowa City$55
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.